peramivir

Also known as BCX-1812, 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid, BCX 1812, BCX1812, RWJ 270201, RWJ270201, RWJ-270201, peramivir anhydrous

thumb|Exterior of Rapiacta I.V. Bag 300mg (Generic name: Peramivir hydrate). An anti-influenza virus drug administered by intravenous infusion in Japan.

~4 min read

Article

3 sections

Contents

History
References
External links

thumb|Exterior of Rapiacta I.V. Bag 300mg (Generic name: Peramivir hydrate). An anti-influenza virus drug administered by intravenous infusion in Japan.

Peramivir (trade name Rapivab) is an antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. It is approved for intravenous administration.